Single-cell sequencing elucidates the mechanism of NUSAP1 in glioma and its diagnostic and prognostic significance
NUSAP1-based risk models hold potential as predictive and therapeutic tools for personalized glioma treatment. In-depth exploration of NUSAP1's mechanisms in glioblastoma could enhance our understanding of its response to immunotherapy, suggesting that targeting NUSAP1 may offer therapeutic benefits for glioma patients.
Authors
- Jinzhuo Zhao (ORCID: https://orcid.org/0000-0002-7504-779X)
- Wan-Yan Xu (ORCID: https://orcid.org/0009-0005-2871-6347)
- Tian-Hang Yu
- Yu Gu (ORCID: https://orcid.org/0000-0001-8295-2141)
- Wenming Hong (ORCID: https://orcid.org/0000-0002-1143-8046)
- Haochen Dai (ORCID: https://orcid.org/0009-0000-7414-0469)
- Mengyu Zhao
- Lina Wang (ORCID: https://orcid.org/0000-0001-8133-3349)
- Jiafeng Xu (ORCID: https://orcid.org/0000-0003-1411-2153)
- Guanjun Chen (ORCID: https://orcid.org/0009-0003-8164-6670)
- Dong-Hui Chen
- Cun-Zhi Wang
- Zhenhui Shen (ORCID: https://orcid.org/0009-0002-0978-9127)
- Fang Zhang (ORCID: https://orcid.org/0000-0002-9944-7448)
Institutions
- Anhui Medical University (CN)
- First Affiliated Hospital of Anhui Medical University (CN)
- Lu'an First People's Hospital (CN)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2025-02-05
- DOI
- https://doi.org/10.3389/fimmu.2025.1512867
- Citations
- 1
- Primary Topic
- Single-cell and spatial transcriptomics
- Type
- article
- Field-Weighted Citation Impact
- 0.81